Navigation Links
Impliant Granted Two New U.S. Patents and Successfully Defends European Patent Opposition Case
Date:6/9/2009

PRINCETON, N.J., June 9 /PRNewswire/ -- Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that the European Patent Office has confirmed the validity of one of its key patents following an Opposition by Archus Orthopedics, Inc. (Redmond, WA) that concluded with oral proceedings on May 12, 2009 in Munich, Germany. This patent (EP1578314 B1), originally issued to Impliant on May 30, 2007, involves among others the company's flagship product, the TOPS System, a Total Posterior Arthroplasty device designed to treat lumbar spinal stenosis with or without facet arthrosis and spondylolisthesis. Archus challenged the patent on the grounds of being too broad, but the European Patent Office rejected the opposition and upheld every claim of the patent.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO )

Impliant also announced that it has been granted two additional patents in the United States. The first (US 7537613), granted on May 26, 2009, is another patent that directs to the company's TOPS System. The second (US 20050197705), already a patent in Europe (EP1646338), entails a unique translateral spinal disc replacement.

"We are very pleased by the outcome of these procedings," said Todd Potokar, President and CEO of Impliant. "The successful defense of one of our main patents in Europe coupled with the addition of two new patents in the U.S. further strengthens our robust IP portfolio."

Impliant is applying cutting-edge materials and crossbar biomechanical techniques to develop a new class of spine arthroplasty devices that target over 40% of the patients worldwide who undergo fusion surgery and could benefit from a Total Posterior Arthroplasty solution
'/>"/>

SOURCE Impliant, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Impliant Restarts European Clinical Activities for Patented TOPS(TM) Spine System
2. PREOS(R) Granted U.S. Orphan Drug Status for Treatment of Hypoparathyroidism
3. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
4. USC granted $8.4 million for autism research
5. Aida Granted Additional Anti-Cancer Patent
6. CME LLC Granted Five-Year Full Approval by the American Psychological Association
7. ActiPatch(TM) Granted Market Clearance by the Food & Drug Administration in the Kingdom of Jordan
8. TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA
9. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
10. Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS
11. Phylonix granted broad European patent for transplanting human cells into zebrafish

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive game, S... Touch. , Mountain View, ... popular and addictive game, SplitWords, is now av...is designed to help banish that ,tip of the tongue...ain game challenges the brain by encouraging user...
(Date:11/20/2009)...J, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST Pharma...ting of Shareholders will be held on Monday, Decem...sider approval of two special resolutions. The fir...the sale of all or substantially all of the assets...or in the asset purchase agreement dated November ...
(Date:11/20/2009)....J., Nov. 20 Rates of in...peaked in late October, but the pandemic flu virus...all age groups, including the elderly, according t...NYSE: DGX ), the world,s leading provider of dia...In its most recent Quest Diagnostics Health Trends...
(Date:11/20/2009).... 20 The following is a... the Nevada Health Care Association: ,, "The Ne...hanks Senate Majority Leader Harry Reid for his le... our goal of protecting every Nevada seniors, ongo...rving the strength and viability of our state,s vi...
(Date:11/20/2009)...November 20, 2009Emergency medical service (EMS) p...350,000 cardiac arrests each year. Only 5 to 10 p...rvive. Better quality cardiopulmonary resuscitati... be associated with better patient outcome. The R...est clinical research network to study prehospital...
Breaking Medicine News(10 mins):Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...king research into treating malaria infections in ..., Director of the Wellcome Trust-funded Shoklo Mal...ternational recognition. Professor Nosten today re...veloping countries, presented by the Institut de F...
...lth Insurance Under Purina(R) Brand Is Comprehensi...Use, ST. LOUIS, June 11 Millions of pet owners c...ds and they want to provide them,with the best car...longer than ever before. Many medical advances onc...
...e 11 HMS Holdings Corp. (Nasdaq:,HMSY) today anno...,Healthcare Conference, which will be held June 24... Chief Financial Officer of HMS Holdings Corp.,wil...p://www.hmsholdings.com/news/presentations.asp . T...
...: For Dan Savage, surviving testicular cancer has...d taking more adventurous decisions, and he says, ...t things that has happened to him. But as he appro...ow on he will have no regular medical checks that ...
...s say that while police are using their resources ...asier to secure convictions for - the majority of ...ld are still avoiding prosecution. Currently only ...lnerable children open to unmonitored paedophile p...
...its weren,t limited to high-risk women, study find...-- A drug already approved to reduce the risk of b... the risk for other women. , A new analysis finds ...ancer, compared with women who did not take the dr...
Other Medicine News:Health News:Maternal malaria researcher wins prestigious international prize 2Health News:Maternal malaria researcher wins prestigious international prize 3Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 2Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 3Health News:New PurinaCare(TM) Pet Health Insurance Helps Offer Dogs and Cats a Lifetime of Health and Happiness 4Health News:Cancer was one of the best things to happen to me ... but I worry about the future 2Health News:Sex offenders register provides limited protection for children 2Health News:Raloxifene Cuts Risk of Certain Type of Breast Cancer 2
(Date:11/20/2009)... Nov. 20 /PRNewswire-FirstCall/ -- Landauer, In...he fiscal fourth quarter and full year of 2009 pre...mpany will host a conference call for investors on...ime. Investors may access the live call by dialing...), or 480-629-9835 (international callers), or by ...
(Date:11/20/2009)...Nov. 20 Reportlinker.com announces... its catalogue. ,, Pipettes & Pipettors - ...portlinker.com/p0164373/Pipettes--Pipettors---A-Gl...&utm_medium=pr&utm_campaign=prnewswire ,...gral part of any research laboratory. Large-scale ...
(Date:11/20/2009)... and LONDON, Nov. 20 Bos...nounced that it has received 510(k) clearance from...E Mark approval to market its WallFlex® Fully...ignant esophageal strictures (obstructions) caused...ctable esophageal cancer. ,, (Photo: http://...
Breaking Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Fruit juices contain more vitamin C than their labels indicate 58852 1Fruit juices contain more vitamin C than their labels indicate 58852 2Focused Radiation Protects Tumor Patients Brain Function 58850 1Focused Radiation Protects Tumor Patients Brain Function 58850 2Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 1Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 2Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 3Wonderful 28R 29 Pistachios Invites America to 26quot 3BGet Crackin 26quot 3B 58847 4
...and,worldwide leader in radiation treatment planni...ced that three sites have delivered clinical,treat...tensity Modulated,Radiotherapy (IMRT) treatment pl...burgh, Pennsylvania, Erasmus Medical Center in Rot...n Hospital in Milwaukee,Wisconsin, have all begun ...
...Clinical Profile of This Novel,Anti-Cancer Agent U...ts,With Hormone Refractory Prostate Cancer (HRPC),...herapeutics company,today announced that the prima...n study was met. The study showed that even single... metastases could produce,increasing clinical bene...
Other Medicine Technology:CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System 2Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 2Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 3Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 4
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products: